{"data":{"id":"us-ky/krs-315.408","jurisdiction":"us-ky","citation":"KRS 315.408","heading":"Electronic track and trace system.","body":"(1) The board shall not require the use of an electronic track and trace system to\ninitiate, provide, receive, or maintain a pedigree by a person or entity licensed to\npossess, distribute, dispense, or administer prescription drugs for use by an end user\nuntil the FDA develops and implements standards for identification, validation,\nauthentication, and tracking and tracing of prescription drugs pursuant to 21 U.S.C.\nsec. 355e. The electronic track and trace system requirements by the board shall\nmeet the FDA's standards for all prescription drugs covered by the FDA standards.\n(2) Upon implementation of FDA standards for an electronic track and trace system, the\nrequirements relating to a pedigree in KRS 315.406 shall be superseded by the FDA\nstandards and shall not apply to any prescription drugs specified in the FDA\nstandards.\n(3) Prior to promulgation of any administrative regulation under KRS Chapter 13A that\nrequires the use of an electronic track and trace system, the board shall consult with\nmanufacturers, wholesale distributors, and pharmacies regarding implementation of\nthe electronic track and trace system requirements and publish a report on its Web\nsite about implementation issues, including but not limited to universal availability,\ntechnical and opera tional feasibility, and reliability for manufacturers, wholesale\ndistributors, and pharmacies.","path":["KRS Chapter 315"],"source_url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=31046","current_through":"Includes enactments through the 2026 Regular Session","vintage":"09/05/2026","retrieved_at":"2026-09-05T20:58:12Z","sha256":"e0e702e7e3761226bf973b2e7a370deaac4e1a8e701dca0347d86be122185b21","source_id":"us-ky","stale":false,"prev":"us-ky/krs-315.406","next":"us-ky/krs-315.410"},"notice":"GroundRules: Original legal text. Not legal advice."}
